SG11201607530XA - Hexose derivatives, preparation and uses thereof - Google Patents

Hexose derivatives, preparation and uses thereof

Info

Publication number
SG11201607530XA
SG11201607530XA SG11201607530XA SG11201607530XA SG11201607530XA SG 11201607530X A SG11201607530X A SG 11201607530XA SG 11201607530X A SG11201607530X A SG 11201607530XA SG 11201607530X A SG11201607530X A SG 11201607530XA SG 11201607530X A SG11201607530X A SG 11201607530XA
Authority
SG
Singapore
Prior art keywords
preparation
hexose derivatives
hexose
derivatives
Prior art date
Application number
SG11201607530XA
Other languages
English (en)
Inventor
Maycock Christopher David
Bordalo Ventura Centeno Lima Maria Rita Mendes
Lourenço Eva Correia
Dos Santos Maria Helena Dias
Cunha Miguel Ana Sofia Da
Original Assignee
Faculdade De Ciências Da Universidade De Lisboa
Inst De Tecnologia Química E Biológica António Xavier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faculdade De Ciências Da Universidade De Lisboa, Inst De Tecnologia Química E Biológica António Xavier filed Critical Faculdade De Ciências Da Universidade De Lisboa
Publication of SG11201607530XA publication Critical patent/SG11201607530XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11201607530XA 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof SG11201607530XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461953392P 2014-03-14 2014-03-14
PCT/PT2015/050001 WO2015137838A1 (fr) 2014-03-14 2015-03-13 Dérivés d'hexose, leur préparation et utilisations

Publications (1)

Publication Number Publication Date
SG11201607530XA true SG11201607530XA (en) 2016-10-28

Family

ID=53264710

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201607530XA SG11201607530XA (en) 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof
SG10201807891UA SG10201807891UA (en) 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201807891UA SG10201807891UA (en) 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof

Country Status (12)

Country Link
US (2) US11708387B2 (fr)
EP (1) EP3116886A1 (fr)
JP (2) JP7067867B2 (fr)
KR (3) KR102401853B1 (fr)
CN (2) CN106573952A (fr)
BR (1) BR112016021231B1 (fr)
CA (1) CA2942635C (fr)
IL (1) IL247531B (fr)
MX (1) MX2016011808A (fr)
RU (1) RU2731563C2 (fr)
SG (2) SG11201607530XA (fr)
WO (1) WO2015137838A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016011808A (es) * 2014-03-14 2017-05-09 Faculdade De Ciências Da Univ De Lisboa Derivados de hexosa, preparacion y usos de los mismos.
FR3061013B1 (fr) * 2016-12-22 2020-04-17 Greenpharma Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique
CA3082696A1 (fr) 2017-11-13 2019-05-16 Extremochem, Lda. Amides glycosyles neutres et acides glucuronides dianioniques en tant que stabilisants pour des molecules biologiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060099567A1 (en) 2004-04-08 2006-05-11 Biomatrica, Inc. Integration of sample storage and sample management for life science
PT103442A (pt) * 2006-02-24 2007-08-31 Stab Vida Investigacao E Servi Derivados sintéticos de manosil-glicerato para a estabilização e/ou preservação de biomateriais
PT103441A (pt) 2006-02-24 2007-08-24 Stab Vida Investigacao E Servi Utilização de solutos compatíveis para melhorar o desempenho de técnicas utilizando materiais biológicos imobilizados
DE102010038496A1 (de) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilisierte flüssige enzymhaltige Tensidzubereitung
DE102011118027A1 (de) * 2011-09-12 2013-03-14 Henkel Ag & Co. Kgaa Verfahren zur Anpassung eines Hydrolytischen Enzyms an eine das hydrolytische Enzym stabilisierende Komponente
MX2016011808A (es) * 2014-03-14 2017-05-09 Faculdade De Ciências Da Univ De Lisboa Derivados de hexosa, preparacion y usos de los mismos.
JP2020097767A (ja) 2018-12-18 2020-06-25 株式会社東芝 表面処理剤、これを用いた積層体、及び無電解めっき製品

Also Published As

Publication number Publication date
JP7077361B2 (ja) 2022-05-30
JP7067867B2 (ja) 2022-05-16
RU2016140337A3 (fr) 2018-10-30
RU2731563C2 (ru) 2020-09-04
EP3116886A1 (fr) 2017-01-18
KR20240045328A (ko) 2024-04-05
CA2942635C (fr) 2022-12-06
SG10201807891UA (en) 2018-10-30
US11708387B2 (en) 2023-07-25
BR112016021231B1 (pt) 2021-07-27
KR20160145584A (ko) 2016-12-20
CN115448964A (zh) 2022-12-09
JP2017516838A (ja) 2017-06-22
KR102651029B1 (ko) 2024-03-25
JP2020183383A (ja) 2020-11-12
KR20220153571A (ko) 2022-11-18
RU2016140337A (ru) 2018-04-17
IL247531B (en) 2021-04-29
BR112016021231A2 (pt) 2018-07-10
MX2016011808A (es) 2017-05-09
US20180170955A1 (en) 2018-06-21
IL247531A0 (en) 2016-11-30
CA2942635A1 (fr) 2015-09-17
US20230357301A1 (en) 2023-11-09
KR102401853B1 (ko) 2022-05-25
WO2015137838A1 (fr) 2015-09-17
CN106573952A (zh) 2017-04-19

Similar Documents

Publication Publication Date Title
IL252346B (en) Heteroaryl compounds, their preparation and use
HK1232169A1 (zh) 取代的 -苯基哌啶，其製備和用途
HK1256752A1 (zh) 取代的苯並咪唑，它們的製備和它們作為藥物的用途
GB201408673D0 (en) Medicaments,uses and methods
IL252397A0 (en) Pharmaceutical preparations, their preparation and uses
IL290114A (en) Pharmaceutical preparations, their preparation and uses
LT3229843T (lt) Farmacinė kompozicija, jos paruošimo būdas ir naudojimas
IL247531A0 (en) The history of ksuz, their preparation and uses
ZA201608621B (en) Silicon-containing azodicarboxamides, their preparation and use
PT3288575T (pt) Complexo de proteína-melanina bioassimilável, sua preparação e utilizações
PL3386988T3 (pl) Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie
PT3166945T (pt) Derivados de triazolopirimidinona ou de triazolopiridinona inovadores e utilização dos mesmos
PL3122184T3 (pl) Mikrokapsułki chlomazonu, ich wytwarzanie i zastosowanie
IL249897A0 (en) 2-oxo-4,3-dihydropyridine-5-carboxylates and their use
HRP20182167T1 (hr) Derivati benzilhidroksida, njihova priprava i njihova terapeutska uporaba
IL249073A0 (en) Cytin-glucan complex, its preparation and uses
GB201513143D0 (en) Safe n easy F&S
GB201401598D0 (en) Cells, preparation, uses, methods and components
TH1501007100A (th) องค์ประกอบทางเภสัชกรรม, การเตรียม และการใช้ของมัน